• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤何时开始再增殖?放射治疗期间前列腺癌的发病时间。

When tumor repopulation starts? The onset time of prostate cancer during radiation therapy.

机构信息

Department of Radiation Oncology, James Cancer Hospital & Solove Research Institute, The Ohio State University, Columbus, 43210, USA.

出版信息

Acta Oncol. 2010 Nov;49(8):1269-75. doi: 10.3109/0284186X.2010.509737. Epub 2010 Aug 16.

DOI:10.3109/0284186X.2010.509737
PMID:20712432
Abstract

PURPOSE

To analyze published clinical data and provide a preliminary estimate of tumor repopulation rate and its onset time during radiation therapy for prostate cancer.

METHODS

Data on prostate cancer treated with external beam radiotherapy (EBRT) by Perez et al. (2004), Amdur et al. (1990) and Lai et al. (1991) were analyzed in this study. The stage-combined pelvic control rate from Perez et al. was calculated to be 0.95±0.01, 0.87±0.02, and 0.72±0.04 for patients treated ≤7 weeks, 7.1-9 weeks, and >9 weeks respectively. Based on the Linear-Quadratic model, extended to account for tumor repopulation, the least χ² method was used to fit the clinical data and derive the onset time (T(k)) and effective doubling time (T(d)) for prostate cancer. Similar analysis was performed for the other two datasets.

RESULTS

Best fit was achieved with onset time T(k)=34±7 days and doubling time T(d)=12±2 days. These parameters were independent of the choice of the α/β values currently published in the literature. Analyses of the other two datasets showed T(k)=42±7 days with T(d)=9 ± 3 days, and T(k)=34±6 days with T(d)=34±5 days, respectively. T(k) was found to be dependent on tumor stage.

CONCLUSIONS

Consistent values for onset time T(k) were obtained from different datasets, while the range of doubling time T(d) was large. Tumor repopulation starts no later than 58 days (at 90% confidence level) in the course of EBRT for prostate cancer.

摘要

目的

分析已发表的临床数据,初步估计前列腺癌放射治疗过程中的肿瘤再增殖率及其发生时间。

方法

本研究分析了 Perez 等人(2004 年)、Amdur 等人(1990 年)和 Lai 等人(1991 年)发表的关于前列腺癌接受外束放射治疗(EBRT)的数据。将 Perez 等人的联合盆腔控制率按阶段计算,分别为≤7 周、7.1-9 周和>9 周治疗的患者为 0.95±0.01、0.87±0.02 和 0.72±0.04。基于扩展到考虑肿瘤再增殖的线性二次模型,使用最小 χ²法拟合临床数据,得出前列腺癌的发生时间(T(k))和有效倍增时间(T(d))。对另外两个数据集进行了类似的分析。

结果

最佳拟合的起始时间 T(k)=34±7 天,倍增时间 T(d)=12±2 天。这些参数与目前文献中公布的 α/β 值的选择无关。对另外两个数据集的分析表明,T(k)=42±7 天,T(d)=9±3 天,T(k)=34±6 天,T(d)=34±5 天。T(k)与肿瘤分期有关。

结论

从不同的数据集中获得了一致的起始时间 T(k)值,而倍增时间 T(d)的范围较大。在前列腺癌 EBRT 过程中,肿瘤再增殖最迟不晚于 58 天(90%置信水平)开始。

相似文献

1
When tumor repopulation starts? The onset time of prostate cancer during radiation therapy.肿瘤何时开始再增殖?放射治疗期间前列腺癌的发病时间。
Acta Oncol. 2010 Nov;49(8):1269-75. doi: 10.3109/0284186X.2010.509737. Epub 2010 Aug 16.
2
Impact of tumor repopulation on radiotherapy planning.肿瘤再增殖对放射治疗计划的影响。
Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):220-7. doi: 10.1016/j.ijrobp.2004.09.043.
3
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.调强适形放射治疗所给予的高剂量辐射可改善局限性前列腺癌的治疗效果。
J Urol. 2001 Sep;166(3):876-81.
4
Prostate-specific antigen kinetics following external-beam radiotherapy and temporary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer.外照射放疗后及暂时性(Ir-192)或永久性(I-125)近距离放疗治疗前列腺癌时前列腺特异抗原的动力学变化。
Radiother Oncol. 2010 Jul;96(1):25-9. doi: 10.1016/j.radonc.2010.02.010. Epub 2010 Mar 16.
5
Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.风险适应性雄激素剥夺与强化三维适形放疗治疗前列腺癌:放疗剂量是否影响接受辅助雄激素剥夺治疗患者的结局?一项GICOR研究。
J Clin Oncol. 2005 Sep 20;23(27):6561-8. doi: 10.1200/JCO.2005.09.662.
6
[Conformal radiotherapy for prostate cancer].[前列腺癌的适形放射治疗]
Vopr Onkol. 2010;56(2):215-9.
7
Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan.使用质子增强治疗的前列腺癌高剂量放射治疗II期可行性研究:日本前列腺癌质子束治疗的首次临床试验。
Jpn J Clin Oncol. 2005 Dec;35(12):745-52. doi: 10.1093/jjco/hyi193. Epub 2005 Nov 28.
8
Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.根据2006年放射治疗肿瘤学组-美国放射治疗及肿瘤学学会(RTOG-ASTRO)菲尼克斯共识定义,肥胖对局限性前列腺癌放射治疗后前列腺特异性抗原复发的影响。
Cancer. 2007 Sep 1;110(5):1003-9. doi: 10.1002/cncr.22873.
9
Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.高剂量率近距离放射疗法和外照射治疗前列腺癌的卓越疗效不会因雄激素剥夺而得到改善。
Am J Clin Oncol. 2009 Aug;32(4):342-7. doi: 10.1097/COC.0b013e31818cd277.
10
Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.永久性前列腺植入的同位素选择?基于放射生物学有效性和剂量学对¹⁰³Pd与¹²⁵I的评估。
Semin Urol Oncol. 2000 May;18(2):152-9.

引用本文的文献

1
Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI.利用从 mpMRI 获得的患者特定肿瘤位置和克隆源密度,对前列腺调强放疗进行体素级生物优化。
Radiat Oncol. 2020 Jul 13;15(1):172. doi: 10.1186/s13014-020-01568-6.
2
Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter?每周两次与每周三次中度适形分割放疗治疗前列腺癌:总治疗时间是否重要?
J Cancer Res Clin Oncol. 2019 Jun;145(6):1581-1588. doi: 10.1007/s00432-019-02893-4. Epub 2019 Mar 18.
3
Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation.
前列腺癌质子调强放疗的 II 期研究的长期结果:中分割与超分割的比较。
Radiat Oncol. 2019 Jan 10;14(1):4. doi: 10.1186/s13014-019-1210-7.
4
Repopulation of tumor cells during fractionated radiotherapy and detection methods (Review).分次放疗期间肿瘤细胞的再增殖及检测方法(综述)
Oncol Lett. 2014 Jun;7(6):1755-1760. doi: 10.3892/ol.2014.1990. Epub 2014 Mar 21.
5
Radiobiological comparison of two radiotherapy treatment techniques for high-risk prostate cancer.两种高危前列腺癌放射治疗技术的放射生物学比较
Rep Pract Oncol Radiother. 2013 Feb 8;18(5):265-71. doi: 10.1016/j.rpor.2012.12.006. eCollection 2013.
6
Compensability index for compensation radiotherapy after treatment interruptions.治疗中断后补偿放疗的补偿指数。
Radiat Oncol. 2012 Dec 8;7:208. doi: 10.1186/1748-717X-7-208.
7
Onset time of tumor repopulation for cervical cancer: first evidence from clinical data.宫颈癌肿瘤再增殖的起始时间:来自临床数据的初步证据。
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):478-84. doi: 10.1016/j.ijrobp.2011.12.037. Epub 2012 Mar 2.